$1,838.93 general Payment -- Merck & Co to Dr. Gregory Evans

Payment Details

AI-Powered Analysis of This Payment

The following analysis was generated by artificial intelligence to help patients understand the context, significance, and implications of this pharmaceutical payment. This analysis is not medical or legal advice.

Merck & Co made a $1.8K general payment to Gregory Evans, a Infectious Disease specialist in City, AZ. The payment of $1,838.93 to Dr. Gregory Evans from Merck & Co. in 2025 is for services other than consulting. This payment falls under the 'general' payment type, indicating a broad category of compensation. The payment was made by Merck & Co., a major pharmaceutical company, to a physician specializing in Infectious Disease.

Patient Guidance: What This Payment Means for You

This payment to your doctor is for services rendered and is publicly reported for transparency. Always discuss your treatment options with your healthcare provider and ask about alternatives.

Payment Context: Is This Amount Normal?

Payments for services other than consulting in Infectious Disease can vary widely; this specific amount is not inherently high or low without further benchmarks.

Regulatory Context: Sunshine Act Requirements

This transaction is reported under the Physician Payments Sunshine Act, requiring disclosure of payments from manufacturers to physicians.

Related Topics

This payment is related to the following healthcare transparency topics:

• pharmaceutical-payments
• physician-compensation
• merck-co
• infectious-disease
• cms-open-payments
• healthcare-transparency

Understanding general Payments

general payments are one of several categories of financial transfers from pharmaceutical and medical device companies to physicians that must be reported under the Sunshine Act. Understanding the type and context of a payment is important for evaluating its significance. Not all payments are equal -- a research grant has very different implications than a promotional speaking fee.

Frequently Asked Questions About This Payment

What was this $1.8K payment for?

This was a general payment of $1.8K from Merck & Co to Gregory Evans, categorized as "Compensation for services other than consulting". The payment was reported under the Sunshine Act (CMS Open Payments).

Does Gregory Evans accept pharmaceutical money?

Yes, Gregory Evans received this $1.8K payment from Merck & Co. Under the Sunshine Act, pharmaceutical companies must report all payments to physicians exceeding $10. You can view Gregory Evans's full payment history on the CMS Open Payments database or on this site.

Is it legal for doctors to accept pharma payments?

Yes, it is legal for physicians to receive payments from pharmaceutical companies. The Physician Payments Sunshine Act (2010) requires transparency by mandating that companies report all payments exceeding $10 to CMS. These payments include consulting fees, meals, travel, speaking fees, and research grants. The law does not prohibit payments but ensures public disclosure.

Should I be concerned about this general payment?

A general payment of $1.8K should be evaluated in context. Payment does not imply wrongdoing, but patients have the right to ask their doctor about pharmaceutical relationships.

How do I talk to my doctor about pharma relationships?

You can ask your doctor directly: "Do you receive payments from pharmaceutical companies?" and "Does this affect which medications you prescribe?" Most doctors will answer honestly. You can also verify payment data yourself through CMS Open Payments (openpaymentsdata.cms.gov). Consider asking about generic alternatives and whether the prescribed medication is the best option regardless of manufacturer relationships.

What types of pharma payments are most concerning?

Ownership interests and large consulting/speaking fees are generally considered more significant than meals or small educational grants. Research payments typically fund clinical studies and are common in academic medicine. The total volume and concentration of payments from a single company may be more telling than any individual payment. Patterns matter more than individual transactions.

Does pharma money affect what my doctor prescribes?

Research shows that even small payments can influence prescribing behavior. Studies published in JAMA Internal Medicine found that physicians who received meals costing as little as $20 were more likely to prescribe the promoted brand-name drug. However, many physician-industry interactions are legitimate professional activities. The key is transparency and awareness.

How does this compare to other doctors in Infectious Disease?

To compare this payment against Infectious Disease averages, check the full specialty breakdown on CMS Open Payments. Payment amounts vary widely by specialty and type. Infectious Disease physicians may receive payments for consulting, speaking, or research that are standard for the field. Individual payments should be evaluated in the context of the doctor's full payment history.

What does this payment reveal about Gregory Evans's relationship with Merck & Co?

The payment amount is relatively modest, suggesting it's not for extensive consulting or research. This $1.8K general payment is part of the transparency data reported under the Sunshine Act.

Is this payment amount typical for Infectious Disease?

The payment date is in the future (2025), which might indicate a pre-scheduled or contractual payment.

What should patients do after learning about this payment?

This payment to your doctor is for services rendered and is publicly reported for transparency.

What else should I know about this general payment?

The payment nature specifies 'services other than consulting,' differentiating it from typical advisory roles.

Related Reports

• View Dr. Gregory Evans's full payment report
• Merck & Co full spending report
• Browse all Infectious Disease payments
• Browse all payments in Arizona
• Search for other payments